🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eman Hawy

Loma Linda University Medical Center

ORCID: 0000-0002-9810-8209

Also affiliated with Loma Linda University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset”.

Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset

Ophthalmology(2021)10.1016/j.ophtha.2020.12.012

N/A

3.6DataRank · unranked

166 citations

Patrick Yu‐Wai‐Man, Valério Carelli, Mark L. Moster, Valérie Biousse, Catherine Vignal +55 more

Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation

Ophthalmology and Therapy(2022)10.1007/s40123-022-00611-x

N/A

0.755DataRank · unranked

30 citations

Nancy J. Newman, Patrick Yu‐Wai‐Man, Valérie Biousse, Mark L. Moster, Prem S. Subramanian +79 more

Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy

JAMA Ophthalmology(2024)10.1001/jamaophthalmol.2024.5375

N/A

0.743DataRank · unranked

24 citations

Nancy J. Newman, Valérie Biousse, Valério Carelli, Mark L. Moster, Catherine Vignal‐Clermont +59 more